[Preventive measures for graft-versus-host disease].
Teshima
Takanori
T
D000208:Acute Disease; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D064987:Cell- and Tissue-Based Therapy; D002908:Chronic Disease; D016207:Cytokines; D003713:Dendritic Cells / Q000276:immunology; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018836:Inflammation Mediators; D007519:Isoantigens / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D059630:Mesenchymal Stem Cells / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014019:Tissue Donors
D016207:Cytokines; D007166:Immunosuppressive Agents; D018836:Inflammation Mediators; D007519:Isoantigens